DUBLIN–(BUSINESS WIRE)–The “Apoptosis Assays World Market” report has been added to ResearchAndMarkets.com’s offering.
The market for Apoptosis Assays is led by Drug Discovery & Development applications sector which is estimated at US$1.9 billion in 2022 and is projected to reach US$2.8 billion by 2026.
Stem Cell Research sector is projected to grow by the fastest CAGR of 11.6% during the period 2022-2026 while Clinical & Diagnostic applications sector is expected to follow with 11.3%.
This world market compendium by the publisher, analyzes the market for Apoptosis Assays at high level by product type, detection technology, application, end-use market and geographic regions.
The market is studied for historical/current trends and future forecast in terms of value in US$ for 2019, 2022 and 2026.
Scope of the Report
Product Type
- Assay Kit
- Reagent
- Instrument
- Microplate
Detection Technology
- Flow Cytometry
- Cell Imaging & Analysis System
- Spectrophotometry
- Others
Application
- Drug Discovery & Development
- Clinical & Diagnostic Application
- Basic Research
- Stem Cell Research
End-Use Market
- Pharmaceutical & Biotechnology Companies
- Hospital & Diagnostic Laboratories
- Academic & Research Institutes
Companies Mentioned
- Abbvie, Inc.
- Abcam PLC
- Abnova Corporation
- Amgen, Inc.
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- R&D Systems, Inc.
- Novus Biologicals, LLC
- Biotek Instruments, Inc.
- Biotium, Inc.
- Canvax Biotech S.L.
- Creative Bioarray
- Danaher Corporation
- GE Healthcare
- Genecopoeia, Inc.
- Geno Technology, Inc.
- Liminal Biosciences, Inc.
- Merck KGaA
- Novartis AG
- Perkinelmer, Inc.
- Pfizer, Inc.
- Promega Corporation
- Sartorius AG
- Takara Bio, Inc.
- Thermo Fisher Scientific, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/3wko2o
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900